| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REGULAR ARTICLES |



*
Institute of Pathophysiology, Semmelweis University Medical School,
Budapest, Hungary
Kidney Disease Section, National Institute of Diabetes and Digestive and
Kidney, National Institutes of Health, Bethesda, Maryland
Renal Cell Biology Section, National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of Health, Bethesda,
Maryland
§
Laboratory of Chemoprevention, National Cancer Institute, National
Institutes of Health, Bethesda, Maryland
Correspondence to Dr. Jeffrey Kopp, Building 10, Room 3N116, National Institutes of Health, Bethesda, MD 20892-1268. Phone: 301-594-3403; Fax: 301-402-0014; E-mail: jbkopp{at}nih.gov
Abstract. Renal pathology in mice that are transgenic for the murine albumin enhancer/promoter linked to a full-length porcine transforming growth factor-ß1 (TGF-ß1) gene has been described previously. In these mice, transgene expression is limited to the liver and the plasma level of TGF-ß is increased. The earliest renal pathologic change is glomerulosclerosis, at 3 wk of age, and this is followed by tubulointerstitial fibrosis. In this study, it was hypothesized that circulating TGF-ß1 increases renal extracellular matrix accumulation and activates local TGF-ß gene expression. Immunostaining at 5 wk revealed increased amounts of collagen I and III within the mesangium, glomerular capillary loops, and interstitium, while the amount of collagen IV was normal. Similarly, Northern analysis showed increased expression of mRNA encoding collagen I and III, as well as biglycan and decorin, while the expression of collagen IV was unchanged. These changes began as early as 1 wk of age, a time before the appearance of glomerulosclerosis. To evaluate matrix degradation, collagenase IV activity was evaluated by gelatin zymography and an increase in matrix metalloproteinase-2 was found. Finally, the production of tissue inhibitors of metalloproteinase was evaluated. Tissue inhibitor of metalloproteinase-1 (TIMP-1) mRNA was increased 18-fold, while TIMP-2 and TIMP-3 were unchanged. In 2-wk-old transgenic kidney, local expression of TGF-ß1, ß2, and ß3 protein was similar to wild-type mice. In 5-wk-old transgenic mice, TGF-ß1 and ß2 protein was present in increased amounts within glomeruli, and renal TGF-ß1 mRNA was increased threefold. It is concluded that elevated levels of circulating TGF-ß1 may act on the kidney to increase matrix protein production and decrease matrix remodeling. Only after glomerulosclerosis is established does local glomerular overproduction of TGF-ß become manifest.
This article has been cited by other articles:
![]() |
W.-Z. Ying, K. Aaron, and P. W. Sanders Mechanism of dietary salt-mediated increase in intravascular production of TGF-{beta}1 Am J Physiol Renal Physiol, August 1, 2008; 295(2): F406 - F414. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tan, J. Zhang, X. Tan, X. Zhang, J. Yang, and Y. Liu Downregulation of SnoN Expression in Obstructive Nephropathy Is Mediated by an Enhanced Ubiquitin-Dependent Degradation J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2781 - 2791. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bolbrinker, S. Markovic, M. Wehland, W. B. W. H. Melenhorst, H. van Goor, and R. Kreutz Expression and Response to Angiotensin-Converting Enzyme Inhibition of Matrix Metalloproteinases 2 and 9 in Renal Glomerular Damage in Young Transgenic Rats with Renin-Dependent Hypertension J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Quan, T. He, S. Kang, J. J. Voorhees, and G. J. Fisher Solar Ultraviolet Irradiation Reduces Collagen in Photoaged Human Skin by Blocking Transforming Growth Factor-{beta} Type II Receptor/Smad Signaling Am. J. Pathol., September 1, 2004; 165(3): 741 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Sanders Salt Intake, Endothelial Cell Signaling, and Progression of Kidney Disease Hypertension, February 1, 2004; 43(2): 142 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, X. Zhang, Y. Li, and Y. Liu Downregulation of Smad Transcriptional Corepressors SnoN and Ski in the Fibrotic Kidney: An Amplification Mechanism for TGF-{beta}1 Signaling J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3167 - 3177. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Z. Ying and P. W. Sanders The interrelationship between TGF-{beta}1 and nitric oxide is altered in salt-sensitive hypertension Am J Physiol Renal Physiol, November 1, 2003; 285(5): F902 - F908. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bao, J. Zhou, V. M. Holers, and R. J. Quigg Excessive Matrix Accumulation in the Kidneys of MRL/lpr Lupus Mice Is Dependent on Complement Activation J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2516 - 2525. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Boffa, Y. Lu, S. Placier, A. Stefanski, J.-C. Dussaule, and C. Chatziantoniou Regression of Renal Vascular and Glomerular Fibrosis: Role of Angiotensin II Receptor Antagonism and Matrix Metalloproteinases J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1132 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dai, J. Yang, and Y. Liu Transforming Growth Factor-beta 1 Potentiates Renal Tubular Epithelial Cell Death by a Mechanism Independent of Smad Signaling J. Biol. Chem., March 28, 2003; 278(14): 12537 - 12545. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Schnaper, T. Hayashida, S. C. Hubchak, and A.-C. Poncelet TGF-beta signal transduction and mesangial cell fibrogenesis Am J Physiol Renal Physiol, February 1, 2003; 284(2): F243 - F252. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pavenstadt, W. Kriz, and M. Kretzler Cell Biology of the Glomerular Podocyte Physiol Rev, January 1, 2003; 83(1): 253 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Dahly, K. M. Hoagland, A. K. Flasch, S. Jha, S. R. Ledbetter, and R. J. Roman Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R757 - R767. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okada, T. Inoue, Y. Kanno, T. Kobayashi, Y. Watanabe, J. B. Kopp, R. M. Carey, and H. Suzuki Interstitial Fibroblast-Like Cells Express Renin-Angiotensin System Components in a Fibrosing Murine Kidney Am. J. Pathol., March 1, 2002; 160(3): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. MARGETTS, M. KOLB, T. GALT, C. M. HOFF, T. R. SHOCKLEY, and J. GAULDIE Gene Transfer of Transforming Growth Factor-{beta}1 to the Rat Peritoneum: Effects on Membrane Function J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2029 - 2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Y. Chin, A. Mohsenin, S. X. Li, A. M. K. Choi, and M. E. Choi Stimulation of pro-{alpha}1(I) collagen by TGF-{beta}1 in mesangial cells: role of the p38 MAPK pathway Am J Physiol Renal Physiol, March 1, 2001; 280(3): F495 - F504. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cosgrove, K. Rodgers, D. Meehan, C. Miller, K. Bovard, A. Gilroy, H. Gardner, V. Kotelianski, P. Gotwals, A. Amatucci, et al. Integrin {alpha}1{beta}1 and Transforming Growth Factor-{beta}1 Play Distinct Roles in Alport Glomerular Pathogenesis and Serve as Dual Targets for Metabolic Therapy Am. J. Pathol., November 1, 2000; 157(5): 1649 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gagliano, B. Arosio, D. Santambrogio, M. R. Balestrieri, G. Padoani, J. Tagliabue, S. Masson, C. Vergani, and G. Annoni Age-Dependent Expression of Fibrosis-Related Genes and Collagen Deposition in Rat Kidney Cortex J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2000; 55(8): 365B - 372. [Abstract] [Full Text] |
||||
![]() |
M. Isono, A. Mogyorosi, D. C. Han, B. B. Hoffman, and F. N. Ziyadeh Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney Am J Physiol Renal Physiol, May 1, 2000; 278(5): F830 - F838. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mogyorosi and F. N. Ziyadeh GLUT1 and TGF-{beta}: the link between hyperglycaemia and diabetic nephropathy Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2827 - 2829. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673